Tenofovir-Based Highly Active Antiretroviral Therapy Is Associated with Superior CD4 T Cells Repopulation Compared to Zidovudine-Based HAART in HIV 1 Infected Adults

International Journal of Chronic Diseases
Vitus Sambo BadiiDaniel Edem Kpewou

Abstract

Tenofovir-based highly active antiretroviral therapy (HAART) is one of the preferred first-line therapies in the management of HIV 1 infection. Ghana has since 2014 adopted this recommendation; however there is paucity of scientific data that reflects the safety and efficacy of the tenofovir-based therapy compared to zidovudine in the Ghanaian health system. This study sought to assess the comparative immune reconstitution potential between tenofovir and zidovudine-based HAART regimens, which includes lamivudine and efavirenz in combination therapy. It also aimed to investigate the adverse drug reactions/events (ADREs) associated with pharmacotherapy with these agents in a total of 106 HAART naïve HIV patients. The study included 80 patients in the tenofovir cohort while 26 patients were on the zidovudine regimen. The occurrence of HIV comorbidities profile was assessed at diagnosis and throughout the study period. The baseline CD4 T cells count of the participants was also assessed at diagnosis and repeated at a median period of five months (range 4-6 months), after commencing treatment with either tenofovir- or zidovudine-based HAART. After five months of the HAART, the tenofovir cohort recorded higher CD4 T cell count change...Continue Reading

References

Aug 17, 2002·Antimicrobial Agents and Chemotherapy·Sabine FranckeLawrence E Mathes
Dec 20, 2003·The Journal of the Association of Nurses in AIDS Care : JANAC·Rita Verheggen
Jan 20, 2006·The New England Journal of Medicine·Joel E GallantUNKNOWN Study 934 Group
May 23, 2008·Archives of Disease in Childhood·Mary S FewtrellAlan Lucas
Aug 19, 2008·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Marco FloridiaStefano Vella
Sep 2, 2009·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Anupam JenaAjay Wanchu
May 29, 2010·AIDS Research and Therapy·Vincent C MarconiUNKNOWN Infectious Disease Clinical Research Program HIV Working Group (IDCRP)
Jun 1, 2011·PloS One·Vincent C MarconiUNKNOWN Infectious Disease Clinical Research Program (IDCRP) HIV Working Group
Aug 23, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Benjamin H ChiJeffrey S A Stringer
Jun 19, 2013·Immunological Reviews·Mirko Paiardini, Michaela Müller-Trutwin
Jan 10, 2014·AIDS Research and Human Retroviruses·Jessica L CastilhoTimothy R Sterling
Jul 24, 2015·The Journal of Antimicrobial Chemotherapy·Nadezda ApostolovaJuan V Esplugues
Jan 15, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anjali JoshiHimanshu Garg
Mar 11, 2016·Cell Host & Microbe·Gilad Doitsh, Warner C Greene
Mar 19, 2016·BMC Infectious Diseases·Richard Ofori-Asenso, Akosua Adom Agyeman
Mar 24, 2016·Current HIV/AIDS Reports·Eileen Scully, Galit Alter
Nov 4, 2016·Nature Reviews. Drug Discovery·Guido FerrariGeorgia D Tomaras
Mar 7, 2017·World Journal of Hepatology·Bircan Kayaaslan, Rahmet Guner

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapies
pharmacotherapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.